Angiotech Pharmaceuticals, Inc.
Angiotech presents positive Adhibit data
Published in Women's Health Law Weekly, May 14th, 2006
The final data set was presented by Lilo Mettler, the study's principal investigator, at the 19th Annual European Congress of Obstetrics and Gynecology in Torino, Italy.
This randomized, controlled, single-blind, clinical study was designed to evaluate the safety and efficacy of Adhibit in reducing the incidence and severity of post-operative adhesions when applied immediately after the removal of uterine fibroids (myomectomy surgery). The study was conducted at six investigational sites in Europe, Canada, and the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
More Articles from Women's Health Law Weekly
- Hospital for Sick Children, Toronto
Adenovirus-mediated gene therapy in osteosarcoma cell lines can be sensitized - Indian National Institute for Research in Reproductive Health
Autoimmune premature ovarian failure was identified with novel antibody blocking agent - Montefiore Medical Center, Bronx
Angiogenic function reacts to the synergy of laulimalide and docetaxel
Mammography for women under 50 appears cost-effective for women with strong family histories- Academic Medical Centre, Amsterdam
Post-term pregnancy incidence may be reduced by membrane sweeping at 41 weeks - Alfred Hospital, Prahran
Researchers' findings from Australia, Brazil and the United States advance HIV/AIDS research - More from this issue of Women's Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
